阿达木单抗成功治疗多发性顽固性坏疽性脓皮病面部病变
Multiple Facial Lesions of Recalcitrant Pyoderma Gangrenosum Successfully Treated with Adalimumab.
作者信息
Kleinfelder Raymond E, Hin Nady, Cubelli Stefanie, Snyder Allan, Kerdel Francisco, Glick Brad
机构信息
Drs. Kleinfelder and Hin are with the Dermatology Residency Program at the LECOMT/Larkin Community Hospital, Palm Springs Campus, in Hialeah, Florida.
Dr. Cubelli is with St. John's Episcopal Hospital in Far Rockaway, New York.
出版信息
J Clin Aesthet Dermatol. 2019 May;12(5):28-32. Epub 2019 May 1.
Abstract
Pyoderma gangrenosum (PG) is a rare, ulcerative, inflammatory skin disease that most commonly presents on the lower legs. Development of PG on the head and neck is exceedingly rare. We present the case of a 52-year-old man with no known history of underlying systemic disease who developed multiple facial lesions of PG that were refractory to both standard and alternative treatment modalities. Clearance of disease was ultimately achieved using adalimumab.
摘要
坏疽性脓皮病（PG）是一种罕见的溃疡性炎症性皮肤病，最常出现在小腿。头颈部发生PG极为罕见。我们报告一例52岁男性患者，无已知潜在系统性疾病史，其面部出现多处PG皮损，对标准和替代治疗方式均无效。最终使用阿达木单抗实现了疾病清除。
相似文献
1
Multiple Facial Lesions of Recalcitrant Pyoderma Gangrenosum Successfully Treated with Adalimumab.阿达木单抗成功治疗多发性顽固性坏疽性脓皮病面部病变
J Clin Aesthet Dermatol. 2019 May;12(5):28-32. Epub 2019 May 1.
2
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病：英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
3
Recalcitrant Pyoderma Gangrenosum of the Face: A Case Report.面部顽固性坏疽性脓皮病：一例报告
Cureus. 2024 Mar 28;16(3):e57136. doi: 10.7759/cureus.57136. eCollection 2024 Mar.
4
Case Report: Triple Combination Therapy for Recalcitrant Perineal Pyoderma Gangrenosum.病例报告：三联疗法治疗顽固性会阴坏疽性脓皮病
J Drugs Dermatol. 2019 Mar 1;18(3):307-310.
5
Adalimumab therapy for recalcitrant pyoderma gangrenosum.阿达木单抗治疗顽固性坏疽性脓皮病。
J Burns Wounds. 2006 Nov 20;5:e8.
6
An update on adalimumab for pyoderma gangrenosum.关于阿达木单抗治疗坏疽性脓皮病的最新进展。
Drugs Today (Barc). 2021 Sep;57(9):535-542. doi: 10.1358/dot.2021.57.9.3293619.
7
Successful Treatment of Severe Pyoderma Gangrenosum and Ulcerative Colitis With Upadacitinib.乌帕替尼成功治疗重症坏疽性脓皮病和溃疡性结肠炎
ACG Case Rep J. 2024 Oct 11;11(10):e01531. doi: 10.14309/crj.0000000000001531. eCollection 2024 Oct.
8
Intestinal Behçet's disease with pyoderma gangrenosum successfully treated with the combination therapy of adalimumab and glucocorticoids.阿达木单抗与糖皮质激素联合治疗成功治愈伴有坏疽性脓皮病的肠道白塞病。
Mod Rheumatol. 2018 Sep;28(5):901-905. doi: 10.3109/14397595.2016.1174327. Epub 2016 May 4.
9
[Infliximab for a girl with refractory pyoderma gangrenosum].英夫利昔单抗治疗一名患有难治性坏疽性脓皮病的女孩
Nihon Rinsho Meneki Gakkai Kaishi. 2008 Dec;31(6):454-9. doi: 10.2177/jsci.31.454.
10
[The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].[生物疗法在炎症性肠病肠外表现及并发症治疗中的作用]
Acta Med Croatica. 2013 Apr;67(2):195-201.
引用本文的文献
1
A rare complication after coronary bypass surgery: Incisional pyoderma gangrenosum.冠状动脉搭桥手术后一种罕见的并发症：切开性坏疽性脓皮病。
North Clin Istanb. 2021 Aug 5;8(4):395-397. doi: 10.14744/nci.2020.73554. eCollection 2021.
2
Pyoderma Gangrenosum as a Presenting Feature of Undifferentiated Spondyloarthropathy with Erosive Inflammatory Arthritis.坏疽性脓皮病作为未分化脊柱关节炎伴侵蚀性炎症性关节炎的首发表现
Case Rep Rheumatol. 2020 Mar 26;2020:1848562. doi: 10.1155/2020/1848562. eCollection 2020.
本文引用的文献
1
Biologic and small-molecule medications in the management of pyoderma gangrenosum.用于坏疽性脓皮病治疗的生物制剂和小分子药物。
J Dermatolog Treat. 2019 May;30(3):264-276. doi: 10.1080/09546634.2018.1506083. Epub 2018 Sep 7.
2
The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.年龄与坏疽性脓皮病临床表现和合并症的关系。
JAMA Dermatol. 2018 Apr 1;154(4):409-413. doi: 10.1001/jamadermatol.2017.5978.
3
Management of Facial Pyoderma Gangrenosum Using Platelet-Rich Fibrin: A Technical Report.使用富血小板纤维蛋白治疗面部坏疽性脓皮病：一份技术报告。
J Oral Maxillofac Surg. 2018 Jul;76(7):1460-1463. doi: 10.1016/j.joms.2018.01.012. Epub 2018 Jan 31.
4
Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis.高压氧疗法治疗与溃疡性结肠炎相关的坏疽性脓皮病。
Intest Res. 2018 Jan;16(1):155-157. doi: 10.5217/ir.2018.16.1.155. Epub 2018 Jan 18.
5
Classic Ulcerative Pyoderma Gangrenosum Is a T Cell-Mediated Disease Targeting Follicular Adnexal Structures: A Hypothesis Based on Molecular and Clinicopathologic Studies.经典型溃疡性坏疽性脓皮病是一种靶向毛囊附属器结构的T细胞介导性疾病：基于分子和临床病理研究的假说
Front Immunol. 2018 Jan 15;8:1980. doi: 10.3389/fimmu.2017.01980. eCollection 2017.
6
Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.用优特克单抗治疗重度顽固性坏疽性脓皮病。
Australas J Dermatol. 2018 May;59(2):131-134. doi: 10.1111/ajd.12744. Epub 2017 Dec 4.
7
Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum.溃疡性结肠炎相关性坏疽性脓皮病与特发性坏疽性脓皮病的临床特征比较。
Chin Med J (Engl). 2017 Nov 20;130(22):2674-2679. doi: 10.4103/0366-6999.218004.
8
Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others.矛盾反应：抗肿瘤坏死因子α药物、乌司奴单抗、司库奇尤单抗、依奇珠单抗及其他药物。
Curr Probl Dermatol. 2018;53:49-63. doi: 10.1159/000479475. Epub 2017 Nov 7.
9
The safety of treatments used in pyoderma gangrenosum.坏疽性脓皮病治疗方法的安全性。
Expert Opin Drug Saf. 2018 Jan;17(1):55-61. doi: 10.1080/14740338.2018.1396316. Epub 2017 Oct 27.
10
Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab.在用阿达木单抗治疗银屑病期间出现的坏疽性脓皮病：优特克单抗的有效性。
Australas J Dermatol. 2017 Nov;58(4):e270-e271. doi: 10.1111/ajd.12545. Epub 2017 Jun 28.
Zotero 插件